Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2024-02-20

FDA Approved: DORZOLAMIDE HYDROCHLORIDE TIMOLOL MALETAE — Supplemental Application (Indoco Remedies Limited)

View source ↗

Summary

FDA approved a supplemental application for a dorzolamide hydrochloride-timolol maleate eye drop manufactured by Indoco Remedies Limited.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Dorzolamide hydrochloride-timolol maleate (dorzolamide hydrochloride and timolol maleate)

Snippet

SUPPL AP for DORZOLAMIDE HYDROCHLORIDE TIMOLOL MALETAE (DDORZOLAMIDE HYDROCHLORIDE TIMOLOL MALEATE)